Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy
A Multi-Center, Open Label, Cross-Over Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy
A Multi-Center, Open Label, Cross-Over Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy
A Multi-Center, Open Label, Cross-Over Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
Status: Enrolling
Updated:  12/31/1969
Austin Epilepsy Care Center
1766
mi
from 98109
Austin, TX
Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy
A Multi-Center, Open Label, Cross-Over Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
Status: Enrolling
Updated: 12/31/1969
Austin Epilepsy Care Center
1766
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy
A Multi-Center, Open Label, Cross-Over Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
Status: Enrolling
Updated:  12/31/1969
VCU Medical Center
2352
mi
from 98109
Richmond, VA
Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy
A Multi-Center, Open Label, Cross-Over Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
Status: Enrolling
Updated: 12/31/1969
VCU Medical Center
2352
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Behavioral and Educational Tools to Improve Epilepsy Care
Behavioral and Educational Tools to Improve Epilepsy Care
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
Behavioral and Educational Tools to Improve Epilepsy Care
Behavioral and Educational Tools to Improve Epilepsy Care
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
1104
mi
from 98109
Phoenix, AZ
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
1104
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
University of Southern California
962
mi
from 98109
Los Angeles, CA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
University of Southern California
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
California Pacific Medical Center
680
mi
from 98109
San Francisco, CA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
California Pacific Medical Center
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
University of Florida Gainesville
2452
mi
from 98109
Gainesville, FL
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
University of Florida Gainesville
2452
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
2457
mi
from 98109
Jacksonville, FL
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
2457
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Miami Children's Hospital
2728
mi
from 98109
Miami, FL
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Miami Children's Hospital
2728
mi
from 98109
Miami, FL
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Medical College of Georgia at Georgia Regents University
2300
mi
from 98109
Augusta, GA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Medical College of Georgia at Georgia Regents University
2300
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center / Epilepsy Center
1731
mi
from 98109
Chicago, IL
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center / Epilepsy Center
1731
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Indiana University
1866
mi
from 98109
Indianapolis, IN
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Indiana University
1866
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Via Christi Comprehensive Epilepsy Center
1435
mi
from 98109
Wichita, KA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Via Christi Comprehensive Epilepsy Center
1435
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Louisiana State University Epilepsy Center of Excellence
2099
mi
from 98109
New Orleans, LA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Louisiana State University Epilepsy Center of Excellence
2099
mi
from 98109
New Orleans, LA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Medicine
2329
mi
from 98109
Baltimore, MD
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Medicine
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
1930
mi
from 98109
Detroit, MI
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
1930
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Saint Barnabas Medical Center
2386
mi
from 98109
Livingston, NJ
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Saint Barnabas Medical Center
2386
mi
from 98109
Livingston, NJ
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Columbia University / Columbia Presbyterian Medical Center
2400
mi
from 98109
New York, NY
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Columbia University / Columbia Presbyterian Medical Center
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
University of Rochester
2161
mi
from 98109
Rochester, NY
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
University of Rochester
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
2279
mi
from 98109
Winston-Salem, NC
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
2016
mi
from 98109
Cleveland, OH
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
2016
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
147
mi
from 98109
Portland, OR
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
2373
mi
from 98109
Philadelphia, PA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
University of Virginia
2283
mi
from 98109
Charlottesville, VA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
2
mi
from 98109
Seattle, WA
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
1616
mi
from 98109
Madison, WI
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated:  12/31/1969
George Washington University
2322
mi
from 98109
Washington,
RNS® System LTT Study
RNS® System Long-term Treatment (LTT) Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
George Washington University
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
766
mi
from 98109
Fresno, CA
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
766
mi
from 98109
Fresno, CA
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2543
mi
from 98109
Bradenton, FL
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2543
mi
from 98109
Bradenton, FL
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1854
mi
from 98109
Paducah, KY
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1854
mi
from 98109
Paducah, KY
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2316
mi
from 98109
Bethesda, MD
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2316
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2474
mi
from 98109
Burlington, MA
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2474
mi
from 98109
Burlington, MA
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1794
mi
from 98109
Grand Rapids, MI
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1794
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1450
mi
from 98109
Rochester, MN
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1961
mi
from 98109
Tupelo, MS
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1961
mi
from 98109
Tupelo, MS
Click here to add this to my saved trials
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1703
mi
from 98109
Chesterfield, MO
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in b.i.d. Administration (Oral Tablets of 2.5 or 10 mg) for a Maximum of 7 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1703
mi
from 98109
Chesterfield, MO
Click here to add this to my saved trials